Travere Therapeutics prices $125M equity offering
- Travere Therapeutics (NASDAQ:TVTX) priced an underwritten public offering of ~7.81M shares at a price to the public of $16.00 per share.
- The gross proceeds from the offering are expected to be $125M.
- The offering is expected to close on November 12, 2024.
- Underwriters have a 30-day option to purchase up to an additional 1.17M shares.
- The stock price dropped 2.3% on Friday during pre-market hours of trading.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。